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Peter Walter is currently an Investigator of the Howard 
Hughes Medical Institute and a Professor in the 
Department of Biochemistry and Biophysics at the 
University of California, San Francisco (UCSF). Having 
earned a bachelor’s degree in chemistry from the Free 
University of Berlin, an MS degree in organic chemistry 
from Vanderbilt University, he studied for his PhD in 
biochemistry at the Rockefeller University where he 
worked with Günter Blobel and identified the signal 
recognition particle that is required for the translocation 
of membrane and secreted proteins in the endoplasmic 
reticulum. Research in his laboratory at UCSF is now 
focused on protein sorting and targeting to the ER and on 
understanding the interplay between ER homeostasis and 
disease. He is a coauthor of the Molecular Biology of the 
Cell, published by Garland Science and now in its fifth 
edition. For two of those editions he worked closely with 
Miranda Robertson, then associated with Garland 
Publishing and now the Editor of BMC Biology, to whose 
Editorial Board she recruited him.
To mark the tenth anniversary of BMC Biology, she 
asked him to cast his mind back to a telephone call.
MR: Peter – The seed of our re-review opt-out policy 
was first sown when you called me from Frankfurt 
airport with a rather surprising proposition: would 
you like to remind me what that was?
PW: Well, if I remember correctly I asked you if BMC 
Biology would publish a paper that had been submitted to 
and reviewed by another journal.
MR: Oh it was worse than that – you wanted our 
undertaking that we would publish the paper on the 
basis of the existing referees’ reports and without 
further review, because you needed that assurance 
before you withdrew the paper from the journal 
where it was still under consideration.
PW: Yes.
MR: What drove you to make that suggestion?
PW: Well I probably was completely jetlagged having 
arrived from the West Coast in Frankfurt and had many 
hours sitting there uncomfortably contemplating our 
frustration with this submission. The paper had been 
submitted, we got reviews back, we had responded to the 
reviewers’ comments, and then we were put in limbo, it 
seems now for months. The paper was in re-review and 
the reviewer just never responded.
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MR: Before we go on with the story, would you just 
briefly explain what the paper was about?
PW: It was the structure of our favorite enzyme IRE1, 
which is a signal transmission molecule that senses 
unfolded proteins in the ER, and then signals in a 
fascinating way – it’s a kinase and nuclease in the same 
polypeptide chain, and the structure showed how it was 
activated by a process of oligomerization. We had pressed 
the journal because it was a structure paper, and one of 
the reviewers requested the coordinates so he or she 
could look at them and then was sitting on the paper, and 
the science was getting stale.
MR: Presumably also the reviewers could have used 
those coordinates to do their own experiments and 
get ahead of you.
PW: Precisely. The never-ending delay was just completely 
unacceptable.
MR: So to get back to the story, I asked you to 
give me I think a few hours to think about your 
proposition, that we should take these papers 
essentially on the basis of anonymous referees’ 
reports, and agree to publish them, if you pulled 
them from the journal that they were currently with. 
I thought it over, discussed it with a colleague, and 
then emailed you “Yes we can”.
So now perhaps you’d like to say what happened 
to the papers in the end.
PW: So basically you were showing us that we had 
another way we could publish this work without 
incurring further delays, and it gave us the strength 
to then send an e-mail to the journal just saying we 
would like to hear a decision on this paper in the next 
24 hours, otherwise please consider the paper formally 
withdrawn. I didn’t feel very good about having to 
put so much pressure on them, making such a strong 
statement.
MR: It must also have been a risk for the postdoc 
whose paper it was?
PW: Yes, I incurred quite a large phone bill in discussing 
our options and philosophy with him, but the postdoc 
was a hundred percent in agreement that we should take 
strong and proactive steps in this case. It was a review 
process completely gone awry.
MR: And what happened when you told the journal 
that you were going to pull the paper?
PW: In 24 hours it was accepted.
MR: And that was a happy ending for you and your 
postdoc – and one way to escape from reviewing 
delays, though not one I think either of us would 
advocate in ordinary circumstances – and of course 
we lost the papers.
PW: But you got a wonderful new reviewing policy out of it.
MR: We did. Clearly there was a need to escape from 
reviewing delays, and during the few hours I asked 
for to think over your proposition, I confronted 
the question – if there is a strong case for doing 
this for these papers, shouldn’t we be doing it 
for everyone’s? And before I told you yes, we had 
resolved on a policy of allowing authors to decide 
whether referees should see their papers again after 
revision – subject to the support of our Editorial 
Board, who turned out to be overwhelmingly in 
favor.
But I do think this case – and indeed our re-
review opt-out policy – raises the question, do 
you not think that by insisting that authors meet 
the requirements of referees, the journal is simply 
protecting the integrity of scientific reporting, 
and ensuring that what comes out in the journal 
is sound?
PW: Yes of course. But some comments are useful and 
make the paper better – they’re actually quite rare in my 
experience – and other comments are just “more could 
be done, more could be done”. Such requests put the 
students and postdocs into endless holding loops, where 
for months, or sometimes even more, they are perform-
ing reviewer experiments, in many cases orthogonal to 
where scientific judgment might say the research should 
be going, or where we would like it to go.
MR: So your argument is that the paper should be 
judged on the basis of what’s in that paper and not 
what might be in another paper if you did some 
more experiments.
PW: Yes. I think it’s one of the maladies of our current 
reviewing practices that reviews get longer and longer, 
papers get longer and longer, a lot of material is buried in 
the mausoleum of supplemental information that nobody 
reads anyway and that’s not properly reviewed either, and 
often the main message is weakened or even lost.
What is missing is decisive editors at the other end of 
the process, because some reviewers’ comments are quite 
useful, while others are simply saying what more can be 
done, without necessarily improving the paper. There’s 
always more that can be done for any paper, but the 
research packaged in the manuscript has already been 
judged to be appropriate for the journal when it’s sent out 
for review. It’s the function of the reviewers to figure out 
if the points that we are trying to conclude are properly 
supported by the data that we show. It’s not the function 
of the reviewer to say whether this paper is appropriate 
for the journal, that’s the editor’s role. I think in many 
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cases—when things get dragged out forever and when 
people get asked to do endless more experiments—it’s 
where the editor needs to step in and clearly state that 
while this would be a nice experiment, it will not be 
required for acceptance of this work. Unfortunately, in 
many instances we find that the editor on the other end 
of the line just isn’t decisive enough.
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